Surgeons will soon be able to literally mend a broken heart using live tissue grown from a patient's very own stem cells, top cardiologists said.
The whole procedure -- harvesting cells from bone marrow, growing tissue and surgically implanting the heart muscle or valve -- could take as little as six weeks and could become routine within three-to-five years, they reported.
Their findings were published in a special issue of the Philosophical Transactions of The Royal Society B in Britain.
One reason heart attacks are so debilitating, even when they are not fatal, is because the human heart does not regenerate. Damaged tissue stays damaged.
Most problems occur with age, when the heart begins to wear out.
"But the highest medical need for tissue-engineered heart valves is in the treatment of congenital heart malformation," which affects nearly 1 percent of all newborns, Simon Hoeurstrup, lead author of one of the studies, said.
Artificial heart valves currently available must be periodically replaced as children grow, leading to suffering and higher death rates than in adults.
Bio-engineered heart muscle that could be grafted onto a patient's living tissue without fear of rejection by the immune system has long been a holy grail of cardiovascular medicine.
Artificial replacements "do the job and save people's lives," said heart surgeon Magdi Yacoub, who coordinated the studies. "But they cannot match the elegant, sophisticated functions of living tissues."
While durable, mechanical hardware increases the risk of bacterial infection in the heart's inner lining, as well as abnormalities in blood flow. Recipients must also take medication to prevent blood clots, boosting the chances of internal bleeding and embolisms.
There are currently two broad techniques for making bio-prosthetic heart valves, and both have serious drawbacks.
Animal grafts, especially from pigs, are readily available, but differ in structure and tend to wear out. Human valves from donors work much better, but are in chronically short supply and can easily provoke immune reactions.
In the tissue engineering approach favored by Yacoub and Hoerstrup, the patient's own stem cells -- taken from bone marrow -- are isolated and expanded in the laboratory using standard cell culture techniques.
They are then "seeded" onto a special matrix in the shape of a heart valve that is positioned in a device called a "bioreactor" which tricks the cells into growing in the right shape.
Once mature, the living-tissue heart valves can be implanted in the patient.
This procedure has already been extensively tested in sheep, but several years of follow-up are required before it can be deemed effective and safe, Hoerstrup said.
LEVERAGE: China did not ‘need to fire a shot’ to deny Taiwan airspace over Africa when it owns ‘half the continent’s debt,’ a US official said, calling it economic warfare The EU has raised concerns about overflight rights following the delay of President William Lai’s (賴清德) planned state visit to the Kingdom of Eswatini after three African nations denied overflight clearance for his charter at the last minute. Taiwanese allies Paraguay and Saint Kitts and Nevis, as well as several US lawmakers and the Inter-Parliamentary Alliance on China (IPAC) condemned China for allegedly pressuring the countries. Lai was scheduled to fly directly to Taiwan’s only African ally from yesterday to Sunday to celebrate the 40th anniversary of King Mswati III’s accession and his 58th birthday, but Seychelles, Mauritius and Madagascar suddenly revoked
China on Wednesday teased in a video an aircraft carrier that could be its fourth, and the first using nuclear power, while making an allusion to Taiwan and vowing to further build up its islands, as it looks to boost maritime power, secure resources and bolster territorial claims. The video, issued on the eve of the 77th founding anniversary of the Chinese People’s Liberation Army Navy, featured fictional officers with names that are homophones of three commissioned aircraft carriers, the Liaoning (遼寧), Shandong (山東) and Fujian (福建). Titled Into the Deep, it showed a 19-year-old named “Hejian” (何劍) joining the group, sparking
BIG YEAR: The company said it would also release its A12 chip the same year to keep a ‘reliable stream of new silicon technologies’ flowing to its customers Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) yesterday said its newest A13 chip is to enter volume production in 2029 as the chipmaker seeks to hold onto its tech leadership and demand for next-generation chips used in artificial intelligence (AI), high-performance-computing (HPC) and mobile applications. TSMC, the world’s biggest contract chipmaker, also unveiled its A12 chip at its annual technology symposium in Santa Clara, California. The A12 chip, which features TSMC’s super-power-rail technology to provide backside power delivery for AI and HPC applications, is also to enter volume production in 2029, a year after the scheduled release of the A14 chip. The technology moves
The final batch of 28 M1A2T Abrams tanks purchased from the US arrived at Taipei Port last night and were transported to the Armor Training Command in Hsinchu County’s Hukou Township (湖口), completing the military’s multi-year procurement of 108 of the tanks. Starting at 12:10am today, reporters observed more than a dozen civilian flatbed trailers departing from Taipei Port, each carrying an M1A2T tank covered with black waterproof tarps. Escorted by military vehicles, the convoy traveled via the West Coast Expressway to the Armor Training Command, with police implementing traffic control. The army operates about 1,000 tanks, including CM-11 Brave Tiger
RSS